News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
847,257 Results
Type
Article (86510)
Company Profile (702)
Press Release (760045)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232693)
Career Advice (4128)
Deals (39721)
Drug Delivery (129)
Drug Development (90987)
Employer Resources (198)
FDA (18111)
Job Trends (17338)
News (396479)
Policy (39749)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (56841)
ALS (104)
Alzheimer's disease (1505)
Antibody-drug conjugate (ADC) (164)
Approvals (18069)
Artificial intelligence (333)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (314)
Cancer (2489)
Cardiovascular disease (210)
Career advice (3535)
Career pathing (34)
CAR-T (176)
Cell therapy (501)
Cervical cancer (22)
Clinical research (73480)
Collaboration (933)
Company closure (2)
Compensation (578)
Complete response letters (30)
COVID-19 (2869)
CRISPR (50)
C-suite (275)
Cystic fibrosis (109)
Data (2365)
Decentralized trials (2)
Denatured (46)
Depression (57)
Diabetes (303)
Diagnostics (6930)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (130)
Drug shortages (33)
Duchenne muscular dystrophy (104)
Earnings (97016)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130235)
Executive appointments (787)
FDA (19544)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (834)
Gene editing (125)
Generative AI (35)
Gene therapy (366)
GLP-1 (862)
Government (5169)
Grass and pollen (6)
Guidances (150)
Healthcare (20890)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (151)
Indications (30)
Infectious disease (3033)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (59)
Intellectual property (102)
Interviews (813)
IPO (17830)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (46)
Layoffs (563)
Leadership (24)
Legal (10114)
Liver cancer (82)
Lung cancer (349)
Lymphoma (161)
Machine learning (9)
Management (65)
Manufacturing (372)
MASH (81)
Medical device (14644)
Medtech (14649)
Mergers & acquisitions (22456)
Metabolic disorders (808)
Multiple sclerosis (89)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (34)
Neuroscience (2124)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (41)
Obesity (433)
Opinion (275)
Ovarian cancer (83)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (163)
Partnered (24)
Patents (258)
Patient recruitment (119)
Peanut (51)
People (65338)
Pharmaceutical (143)
Pharmacy benefit managers (22)
Phase I (22672)
Phase II (31909)
Phase III (24035)
Pipeline (1397)
Policy (179)
Postmarket research (3552)
Preclinical (10235)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (437)
Real estate (7392)
Recruiting (75)
Regulatory (26833)
Reports (58)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (82)
Series A (144)
Series B (94)
Service/supplier (30)
Sickle cell disease (59)
Special edition (19)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4294)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (53)
The Weekly (83)
Vaccines (823)
Venture capitalists (45)
Weight loss (306)
Women's health (40)
Worklife (20)
Date
Today (240)
Last 7 days (993)
Last 30 days (3314)
Last 365 days (35641)
2025 (12796)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (61)
Alaska (7)
Arizona (270)
Arkansas (14)
Asia (50167)
Australia (8835)
California (6681)
Canada (2105)
China (574)
Colorado (289)
Connecticut (307)
Delaware (168)
Europe (115117)
Florida (976)
Georgia (226)
Hawaii (1)
Idaho (64)
Illinois (641)
India (31)
Indiana (343)
Iowa (12)
Japan (178)
Kansas (113)
Kentucky (28)
Louisiana (15)
Maine (70)
Maryland (993)
Massachusetts (5107)
Michigan (252)
Minnesota (432)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (69)
New Hampshire (70)
New Jersey (1875)
New Mexico (31)
New York (1876)
North Carolina (1149)
North Dakota (9)
Northern California (2875)
Ohio (224)
Oklahoma (15)
Oregon (48)
Pennsylvania (1464)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (26)
South Dakota (1)
Southern California (2482)
Tennessee (108)
Texas (1005)
United States (25522)
Utah (199)
Virginia (177)
Washington D.C. (72)
Washington State (615)
West Virginia (3)
Wisconsin (72)
There are 847,257 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Rallybio Downsizes by 40% After Dropping Lead Asset
The company discontinued development last month of its most mature asset, RLYB212, following disappointing mid-stage pharmacokinetic findings in a rare bleeding disorder.
May 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025
May 9, 2025
·
8 min read
Press Releases
Sanuwave Announces Q1 FY2025 Financial Results
May 9, 2025
·
13 min read
Press Releases
Artax Biopharma presents Phase 2a results for oral Nck modulator AX-158 in late-breaking session at the Society for Investigative Dermatology 2025 Annual Meeting
May 9, 2025
·
4 min read
Press Releases
Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 9, 2025
·
15 min read
Press Releases
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
May 9, 2025
·
3 min read
Press Releases
Minghui Pharmaceutical Announces Strategic Partnership and Licensing Agreement with Qilu Pharmaceutical to Develop B7-H3 ADC in Greater China
May 9, 2025
·
3 min read
Press Releases
LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis
May 9, 2025
·
5 min read
Press Releases
Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study
May 9, 2025
·
9 min read
Press Releases
Sirius Therapeutics Announces Nearly $50 Million Financing to Accelerate Clinical Development of siRNA Therapeutics for Cardiometabolic Diseases
May 9, 2025
·
1 min read
1 of 84,726
Next
